The Use of Sphingosine1-Phosphate Receptor (S1pr) Modulators
Silvia Vendetti of Istituto Superiore di Sanità in Italy proposes to improve vaccine immunization by transiently accumulating a high number of antigen-specific precursor cells in the lymph nodes at the time of immunization using agents that modulate cell migration as a new vaccine technology platform.